Schoenberg Mark

CIK 00017635811 companyPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001763581

Recent Transactions

50 trades

Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-11-19$25.00/sh−10,000→ 139,025 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-09-08$19.11/sh−871→ 149,025 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-09-07+1,667→ 149,896 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-09-07−1,667→ 1,667 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-08-11$17.69/sh−10,000→ 148,229 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-07-28$19.14/sh−5,149→ 158,229 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-07-28+10,000→ 163,378 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-06-09$7.37/sh−5,162→ 153,378 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-06-08−10,000→ 10,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-06-08+10,000→ 158,540 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31−3,333→ 3,334 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31+20,000→ 20,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31−3,333→ 6,667 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31−1,334→ 0 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31$11.14/sh−1,896→ 147,103 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31+1,334→ 146,425 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31$11.14/sh−1,896→ 148,540 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31$11.14/sh−759→ 145,666 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31+3,333→ 150,436 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2025-01-31+3,333→ 148,999 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-09-09−1,666→ 3,334 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-09-09$13.08/sh−859→ 145,091 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-09-09+1,666→ 145,950 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-06-10$13.08/sh−5,153→ 144,284 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-06-10−10,000→ 20,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-06-10+10,000→ 149,437 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-03-18$14.05/sh−12,000→ 139,437 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-02-01$15.78/sh−1,894→ 151,437 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-02-01$15.78/sh−1,137→ 149,423 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-02-01$15.78/sh−758→ 149,998 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31−3,333→ 6,667 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31−1,333→ 1,334 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31+3,333→ 153,331 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31$15.74/sh−758→ 149,998 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31$15.74/sh−1,137→ 149,423 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31+1,333→ 150,756 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31+10,000→ 10,000 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31$15.74/sh−1,894→ 151,437 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2024-01-31+2,000→ 150,560 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31−2,000→ 0 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-09-07+5,000→ 5,000 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-06-08+30,000→ 30,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+1,333→ 149,221 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31$10.12/sh−991→ 147,888 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+500→ 147,127 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31+10,000→ 10,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31−2,000→ 2,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31−1,333→ 2,667 total
Award
UroGen Pharma Ltd.$URGN
Employee Stock Option (right to buy)
2023-01-31+30,000→ 30,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+2,000→ 148,879 total

Companies

UroGen Pharma Ltd.
Chief Medical Officer
$URGN

Recent Filings

Address

400 ALEXANDER PARK DRIVE

PRINCETON, NJ, 08540

View on SEC.gov